One positive aspect of this CAR-T cell is that the variable region only recognizes MUC1*, which is only present on tumor cells, and not MUC1, which is also present in healthy tissue, decreasing the “on-target, off-tumor” effects. Here, MUC1 is linked to neoplasm.